X   

Real-Time Quote

Enter Company or MF
   

Bafna Pharmaceuticals Ltd. - Research Center

532989  BAFNAPHAR  Group (T) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

(Rs crore)

Balance sheet

 Mar ' 09Mar ' 08Mar ' 07Mar ' 06Mar ' 05

Sources of funds

Owner's fund
Equity share capital 15.98 9.58 3.87 3.87 2.58
Share application money-- 2.77 0.28-
Preference share capital-----
Reserves & surplus 22.54 2.27 2.50 1.54 1.68

Loan funds

Secured loans 22.70 23.20 15.85 11.46 6.72
Unsecured loans 1.21 1.59 1.26- 0.06
Total 62.43 36.65 26.25 17.14 11.04

Uses of funds

Fixed assets
Gross block 37.16 4.42 4.21 4.95 3.26
Less : revaluation reserve-----
Less : accumulated depreciation 3.45 2.08 1.74 1.37 1.10
Net block 33.70 2.34 2.48 3.58 2.16
Capital work-in-progress 3.19 29.76 23.03 5.39 1.47
Investments-----

Net current assets

Current assets, loans & advances 38.91 18.67 28.45 12.43 13.21
Less : current liabilities & provisions 15.40 14.38 27.76 4.32 5.81
Total net current assets 23.50 4.29 0.70 8.11 7.39
Miscellaneous expenses not written 2.03 0.26 0.05 0.06 0.02
Total 62.43 36.65 26.25 17.14 11.04

Notes:

Book value of unquoted investments-----
Market value of quoted investments-----
Contingent liabilities- 0.14 0.14 0.14-
Number of equity sharesoutstanding (Lacs) 159.81 95.81 38.65 38.65 25.77